Mirati Seeks Differentiation, Amgen Invests In Combos To Dominate KRAS G12C Field

Biomarker Data Confirm Amgen Strategy; Mirati’s Drug Works In CNS

 
• By Mandy Jackson
  
Business competition concept with Colorful paper ships on white background
Amgen was first to market but Mirati is close behind • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences